NCT05915000View on ClinicalTrials.gov

CSF Protein Markers As Prognostic Indicators of the Response to CSF Shunt in Normotensive Hydrocephalus

RecruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

June 13, 2019

Primary Completion Date

June 30, 2025

Study Completion Date

December 31, 2025

Conditions
Beta-amiloid and Phospho-tau Proteins in CSFVentricular Size After CSF ShuntCognitive Impairment and CSF ShuntMotor Impairment Evolution After CSF Shunt
Interventions
DIAGNOSTIC_TEST

Lumbar CSF protein marker determination

The cerebrospinal fluid levels of the Aβ1-42 amyloid, h-tau and phospho-tau proteins will be assessed. The response of patients to the possible implantation of a ventricular peritoneal shunt will be assessed through neuropsychological, gait and ventricular size studies assessed through cerebral magnetic resonance studies.

Trial Locations (2)

46015

RECRUITING

Hospital General Universitario de Valencia, Valencia

RECRUITING

Vicente Vanaclocha, Valencia

All Listed Sponsors
lead

University of Valencia

OTHER